Jazz's neuroscience franchise faces declining Xyrem sales but sees growth in Xywav and Epidiolex. Oncology growth is driven ...

The company’s successful first-generation drug, Xyrem, which treats narcolepsy and idiopathic ... 50mg/mL, an injection for treating adults with previously treated, inoperable or metastatic ...

However, some categories mentioned above have varying dosage forms, such as intramuscular or intravenous (IV) injection.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that zanidatamab-hrii (Ziihera®) 50 mg/mL for injection for intravenous ... particularly in narcolepsy type 2 and i Jazz Pharmaceuticals ...

Fostering healing, resiliency, mindfulness, and healthy relationships. We help you gain control of the issues affecting your life. Our practice truly values people – your experiences, feelings ...

Jazz Pharmaceuticals is a specialty biopharmaceutical company which identifies, develops and commercializes medicines with focus on narcolepsy ... liposome for injection, and others. The company also ...

This week on the KFF Health News Minute: Pain specialists say injections for kids don’t have to hurt so ... A national shortage of Adderall leaves people with narcolepsy struggling to live normal ...

Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is ...

Narcolepsy is a chronic brain disorder that disrupts sleep-wake cycles. People with narcolepsy may feel refreshed after waking but often become very sleepy during the day—this is called excessive ...